Cowin Doubles Down on Flu Antivirals Developer
27 Jun 2024
US$ 19.00
Cowin Capital has made a follow-on investment in the over Rmb200 million (US$27.5 million) series A funding round of ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 05 Jul 2024)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.